129 related articles for article (PubMed ID: 6434585)
1. Extrahypothalamic growth-hormone-releasing factor (GRF) secretion is a rare cause of acromegaly: plasma GRF levels in 177 acromegalic patients.
Thorner MO; Frohman LA; Leong DA; Thominet J; Downs T; Hellmann P; Chitwood J; Vaughan JM; Vale W
J Clin Endocrinol Metab; 1984 Nov; 59(5):846-9. PubMed ID: 6434585
[TBL] [Abstract][Full Text] [Related]
2. Circulating growth hormone releasing factor concentrations in normal subjects and patients with acromegaly.
Penny ES; Penman E; Price J; Rees LH; Sopwith AM; Wass JA; Lytras N; Besser GM
Br Med J (Clin Res Ed); 1984 Aug; 289(6443):453-5. PubMed ID: 6432140
[TBL] [Abstract][Full Text] [Related]
3. [What is the value of determining immunoreactive GHRH in acromegaly?].
Müller B; de Marco D; Bürgi U; Mullis PE
Schweiz Med Wochenschr; 1999 Aug; 129(33):1152-61. PubMed ID: 10483668
[TBL] [Abstract][Full Text] [Related]
4. [Acromegaly, clinical expression of the production of growth hormone releasing factor in pancreatic tumors].
Sassolas G; Chayvialle JA; Partensky C; Berger G; Trouillas J; Berger F; Claustrat B; Cohen R; Girod C; Guillemin R
Ann Endocrinol (Paris); 1983; 44(6):347-54. PubMed ID: 6430207
[TBL] [Abstract][Full Text] [Related]
5. Plasma growth hormone response to growth hormone-releasing factor in acromegalic patients.
Shibasaki T; Shizume K; Masuda A; Nakahara M; Hizuka N; Miyakawa M; Takano K; Demura H; Wakabayashi I; Ling N
J Clin Endocrinol Metab; 1984 Jan; 58(1):215-7. PubMed ID: 6417156
[TBL] [Abstract][Full Text] [Related]
6. Acromegaly and Zollinger-Ellison syndrome secondary to an islet cell tumor: characterization and quantification of plasma and tumor human growth hormone-releasing factor.
Wilson DM; Ceda GP; Bostwick DG; Webber RJ; Minkoff JR; Pont A; Hintz RL; Bensch KG; Kraemer FB; Rosenfeld RG
J Clin Endocrinol Metab; 1984 Nov; 59(5):1002-5. PubMed ID: 6090497
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and outcome of acromegaly induced by ectopic secretion of growth hormone-releasing hormone (GHRH): a French nationwide series of 21 cases.
Garby L; Caron P; Claustrat F; Chanson P; Tabarin A; Rohmer V; Arnault G; Bonnet F; Chabre O; Christin-Maitre S; du-Boullay H; Murat A; Nakib I; Sadoul JL; Sassolas G; Claustrat B; Raverot G; Borson-Chazot F;
J Clin Endocrinol Metab; 2012 Jun; 97(6):2093-104. PubMed ID: 22442262
[TBL] [Abstract][Full Text] [Related]
8. Levels of growth hormone and growth-hormone-releasing factor in cord blood.
Nagashima K; Yagi H; Suzuki S; Noji T; Yunoki H; Kuroume T
Biol Neonate; 1986; 49(6):307-10. PubMed ID: 2875741
[TBL] [Abstract][Full Text] [Related]
9. Medical management of acromegaly due to ectopic production of growth hormone-releasing hormone by a carcinoid tumor.
Melmed S; Ziel FH; Braunstein GD; Downs T; Frohman LA
J Clin Endocrinol Metab; 1988 Aug; 67(2):395-9. PubMed ID: 2899089
[TBL] [Abstract][Full Text] [Related]
10. The interrelationship between the effects of somatostatin and human pancreatic growth hormone-releasing factor on growth hormone release by cultured pituitary tumor cells from patients with acromegaly.
Lamberts SW; Verleun T; Oosterom R
J Clin Endocrinol Metab; 1984 Feb; 58(2):250-4. PubMed ID: 6141175
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the sensitivity of growth hormone secretion to somatostatin in vivo and in vitro in acromegaly.
Kelijman M; Williams TC; Downs TR; Frohman LA
J Clin Endocrinol Metab; 1988 Nov; 67(5):958-63. PubMed ID: 2903171
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.
Losa M; Schopohl J; König A; Müller OA; von Werder K
J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026
[TBL] [Abstract][Full Text] [Related]
13. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
[TBL] [Abstract][Full Text] [Related]
14. [Suppression by dopamine of GH release induced by GRF in a case of acromegaly].
Matsubara M; Odagaki E; Morioka T
Nihon Naibunpi Gakkai Zasshi; 1987 Mar; 63(3):193-7. PubMed ID: 3111898
[TBL] [Abstract][Full Text] [Related]
15. Octreotide suppresses both growth hormone (GH) and GH-releasing hormone (GHRH) in acromegaly due to ectopic GHRH secretion.
Moller DE; Moses AC; Jones K; Thorner MO; Vance ML
J Clin Endocrinol Metab; 1989 Feb; 68(2):499-504. PubMed ID: 2493033
[TBL] [Abstract][Full Text] [Related]
16. Ectopic acromegaly.
Faglia G; Arosio M; Bazzoni N
Endocrinol Metab Clin North Am; 1992 Sep; 21(3):575-95. PubMed ID: 1521513
[TBL] [Abstract][Full Text] [Related]
17. Acromegaly due to a growth hormone-releasing hormone-secreting bronchial carcinoid tumor: further information on the abnormal responsiveness of the somatotroph cells and their recovery after successful treatment.
Boizel R; Halimi S; Labat F; Cohen R; Bachelot I
J Clin Endocrinol Metab; 1987 Feb; 64(2):304-8. PubMed ID: 3098773
[TBL] [Abstract][Full Text] [Related]
18. Ectopic corticotrophin-releasing-factor and growth hormone releasing factor secretion: diagnosis using human pituitary cell culture.
Adams EF; Skrabal F; Carroll D; Loizou M; White MC; Biggins JA; Mashiter K
Horm Res; 1987; 25(2):80-7. PubMed ID: 3106179
[TBL] [Abstract][Full Text] [Related]
19. Preoperative diagnosis of acromegaly by growth hormone-releasing factor radioimmunoassay.
Barth RJ; Constant RB; Parker MW; Mueller GL; Kovacs K; Thorner MO
Mil Med; 1991 Jul; 156(7):375-8. PubMed ID: 1922854
[TBL] [Abstract][Full Text] [Related]
20. Pulsatile growth hormone secretion in patients with acromegaly and normal men: the effects of growth hormone-releasing hormone infusion.
Gelato MC; Oldfield E; Loriaux DL; Merriam GR
J Clin Endocrinol Metab; 1990 Sep; 71(3):585-90. PubMed ID: 2118536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
